Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Thomas, K. A. Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent. J. Biol. Chem. 271, 603–606 (1996).
Carmeliet, P. VEGF as a Key Mediator of Angiogenesis in Cancer. Oncology 69, 4–10 (2005).
Ferrara, N. & Gerber, H. P. The Role of Vascular Endothelial Growth Factor in Angiogenesis. Acta. Haematol. 106, 148–156 (2001).
Ferrara, N. VEGF as a Therapeutic Target in Cancer. Oncology 69, 11–16 (2005).
Tanaka, H., Koyama, Y., Nagai, T., Marumo, H. & Omura, S. Nanaomycins, New antibiotics produced by a strain of Streptomyces. J. Antibiot. 28, 868–875 (1975).
Tsukamoto, M. et al. New Cytotoxic Agents, BE-52440A and B, Produced by a Streptomycete. J. Antibiot. 53, 687–693 (2000).
Iwai, Y. et al. OM-173, New nanaomycin-type antibiotics produced by a strain of Streptomyces. Taxonomy, production, isolation and biological properties. J. Antibiot. 36, 1268–1274 (1983).
Omura, S. et al. Nanaomycins A and B, New Antibiotics Produced by a strain of Streptomyces. J. Antibiot.. 27, 363–365 (1974).
Tanaka, H., Marumo, H., Nagai, T., Okada, M. & Taniguchi, K. Nanaomycins, new antibiotics produced by a strain of Streptomyces. III. A new component, Nanaomycin C, and biological activities of nanaomycin derivatives. J. Antibiot.. 28, 925–930 (1975).
Omura, S., Tanaka, H., Okada, Y. & Marumo, H. Isolation and structure of nanaomycin D, an enantiomer of the antibiotic kalafungin. J. Chem. Soc., Chem. Commun 1976, 320–321 (1976).
Kasai, M. et al. Structure of Nanaomycin E, a new nanaomycin. J. Antibiot. 32, 442–445 (1979).
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63 (1983).
Liu, C., Guo, L., Yao, C., Zhang, R. & Li, Y. Expression and purification of human vascular endothelial growth factor receptor 2 tyrosine kinase in Streptomyces for inhibitor screening. Biotechnol. Appl. Biochem. 50, 113–119 (2008).
Acknowledgements
The study was supported by National S&T Major Special Project on Major New Drug Innovation (Grant No. 2009ZX09301-003) funded by the Ministry of Science and Technology of the People's Republic of China.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jiang, Zk., Guo, Lh., Zhang, Y. et al. 2754A: a new inhibitor of VEGFR-2 isolated from the Streptomyces sp. 2754. J Antibiot 63, 721–723 (2010). https://doi.org/10.1038/ja.2010.117
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ja.2010.117